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Non-melanoma skin cancers (NMSC), namely basal cell
carcinomas (BCC) and squamous cell carcinomas (SCC),
represent the most common form of malignancy in fair-
skinned populations. Solar ultraviolet radiation (UVR),
immunosuppression, and genetic constitution of the host
are well-known risk factors for the development of NMSC.
Epidermodysplasia verruciformis (EV), a rare genetic dis-
ease associated with a high risk of skin cancer, provided the
first clue to a possible role of viruses in human skin carcin-
ogenesis (Jablonska et al, 1972). Due to mutations in either
of the related EVER1 and EVER2 genes, EV patients are
abnormally susceptible to a specific group of related human
papillomavirus genotypes (known as EV HPV) and to the
oncogenic potential of some of these viruses (Orth, 1987;
Ramoz et al, 2002). EV HPV cause widespread, inapparent
infections in the general population (Antonsson et al, 2003).
In EV patients, however, infection leads to persistent wart-
like and macular skin lesions, and premalignant lesions and
SCC develop on sun-exposed areas of the skin in about half
of the patients. EV SCC harbor high copy numbers of
episomal HPV genomes (HPV5 or occasionally HPV8, 14,
17, 20, or 47) and abundant transcripts of the E6 and E7
genes. Phenocopies of EV are exceptionally observed in
immunosuppressed patients. EV is thus a rare experiment
of nature that provides a model for studying the interaction
among potentially oncogenic HPV genotypes, UVR, immu-
nity, and genetic factors (Orth, 1987).
EV HPV DNA sequences have only rarely been detected
in cutaneous premalignant tumors and NMSC in non-EV
patients by Southern blot hybridization, which is sensitive
enough to detect one HPV genome per cell. Using highly
sensitive PCR approaches, however, HPV DNA sequences
were detected in 25%–65% of NMSC in immunocompetent
individuals and in up to 90% of SCC in organ transplant
recipients (OTR), a population at a greatly increased risk of
developing SCC. Similar HPV detection rates were found for
actinic keratoses (AK), the precursor lesion of SCC (re-
viewed in Forslund et al, 2004). These data led researchers
to consider a role for HPV, especially EV HPV types, in the
development of NMSC (Orth, 2004).
Available epidemiological and seroepidemiological data
provide some support to an association between the pres-
ence of EV HPV DNA in normal skin or eyebrow hairs or the
seroreactivity to some EV HPV and an increased risk of AK
and SCC (reviewed in Purdie et al, 2005; Weissenborn et al,
2005). The link between EV HPV and the development of
NMSC in immunocompetent and immunosuppressed individ-
uals, however, remains unclear (reviewed in Orth, 2004). EV
HPV and non-EV cutaneous HPV types represent impressively
diverse, ubiquitous viruses, which are highly prevalent in the
normal skin of healthy adults (Antonsson et al, 2003). A great
diversity of cutaneous HPV types, most frequently EV HPV or
putative novel EV HPV-related types, is detected in AK and
NMSC, and mixed infections are frequently observed in
tumors of OTR patients. Furthermore, it has recently been
shown that cutaneous HPV DNA is common on top of AK,
SCC, and BCC but less prevalent (3.2–7.9-fold) in ‘‘stripped’’
tumors, suggesting that HPV DNA positivity may reflect, in
part, contamination of the surface of the tumors by viral DNA
or particles shed from infected healthy skin (Forslund et al,
2004). It should be also stressed that the tumor HPV DNA
loads are usually low and that it remains unknown whether the
viral sequences are transcriptionally active. The articles by
Weissenborn et al (2005) and by Purdie et al (2005), both
published in this issue of the Journal, address these questions
about the role of EV HPV in skin carcinogenesis.
Weissenborn and colleagues determined HPV DNA loads
by quantitative, type-specific, real-time PCR (Q-PCR) in a
series of specimens of AK, NMSC, perilesional tissues, and
SCC metastases. The majority of the samples were obtained
from immunocompetent patients, and all of them had pre-
viously been found by PCR to harbor EV HPV types 5, 8, 15,
20, 24, or 36. For 40% of the 78 samples yielding conclusive
results, including almost all metastases and half of the
NMSC specimens, viral loads were beyond the detection
limit (two HPV DNA copies in the assay). For the other
specimens, HPV DNA viral loads ranged from 1 copy per
14,200 cell equivalents to 1 copy per 0.02 cell equivalents.
An interesting finding was that the viral loads detected in AK
were significantly higher than in SCC, whereas similar viral
loads were observed for SCC, BCC, and perilesional tissues.
Viral loads of 1 HPV DNA copy per less than 50 cells were
found in 40% of 25 AK, but in only 8% of 13 BCC and 15%
of 13 SCC. Only a few scattered, positive nuclei were de-
tected by a very sensitive in situ hybridization (ISH) method
in sections of NMSC and perilesional skin, in agreement with
their similar low HPV DNA loads detected by Q-PCR. The
localization of HPV DNA in AK was not investigated.
The aims of the study of Purdie and colleagues were both
to search for the presence of EV HPV DNA sequences in
tumor cells and to determine whether these sequences
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were transcriptionally active in SCC (mostly OTR tumors)
and in OTR warts. Specimens were previously found by
PCR to harbor EV HPV types 5, 14, 15, 20, or 23, and further
analyzed by DNA–DNA or RNA–RNA ISH. EV HPV DNA se-
quences were detected in 27.3% of 11 SCC found positive
by PCR, whereas the 2 warts tested were found negative.
Viral transcripts were detected in 38.5% of 13 SCC and
20% of five warts, mainly in the mid to upper epidermal
layers. The four SCC illustrated showed positive areas, or
clusters of positive cells, contrasting with the labeling pat-
tern reported by Weissenborn et al. Nests of enlarged ker-
atinocytes with pale stained cytoplasms, reminiscent of the
cytopathic effect specific of EV HPV, were observed in the
carcinoma in situ region of one OTR SCC. High amounts of
HPV20 DNA and both early and late transcripts were de-
tected in these cells. It seems likely that this case repre-
sents an EV phenocopy. Transcripts of the E2/E4 region
(highly expressed during the late phase of the viral life cycle)
were detected in the other specimens (including three SCC
and one wart found negative for viral DNA by ISH), whereas
no transcripts of the viral E6 and E7 oncogenes or L1 and L2
capsid genes were detected. Unfortunately, HPV DNA loads
were not determined and viral transcripts were not charac-
terized. This would have helped to appreciate the sensitivity
and specificity of the ISH method.
Their data led Weissenborn and colleagues to several
conclusions. Although a passenger state cannot be exclud-
ed, the higher viral loads found in AK, compared with SCC,
are compatible with a carcinogenic role of EV HPV in the
early steps of tumor progression. As for NMSC, the pres-
ence of HPV does not seem to be required for the main-
tenance of the malignant state, and the similar low viral
loads found in perilesional skin may suggest that HPV is
more a passenger than a driver. Whether the presence of
HPV in some tumor cells may have an impact on growth and
invasion properties of the tumor, as proposed by the au-
thors, would be worth considering. The study of Purdie and
colleagues brings some evidence for EV HPV gene expres-
sion in a proportion of SCC, which may suggest an active
rather than a latent or passenger status. The detection and
characterization of viral E6 and E7 transcripts in tumor cells,
however, remain to be achieved. Overall, the data reported
in the two articles should stimulate further work on the
contribution of EV HPV to the development of NMSC.
When considering the possible implications of their find-
ings, the authors refer to functional studies involving ectopic
overexpression of E6 and E7 proteins of EV and non-EV
cutaneous HPV genotypes (reviewed in Storey, 2002). For
instance, the E6 proteins of several cutaneous HPV have
been shown to promote the degradation of the proapoptotic
Bak protein induced in keratinocytes by UVR, and this
antiapoptotic effect could favor the accumulation of UVR-
induced mutations. A crucial question is whether the E6
and E7 proteins of EV HPV or non-EV cutaneous HPV (less
frequently detected in NMSC) behave as oncoproteins
when expressed in vivo, under the control of their own pro-
moter. It should be kept in mind that infection in EV patients
leads to the development of disseminated, widespread,
persistent benign lesions of the skin. About 20 specific HPV
types may be characterized in these lesions, and patients
are usually infected by more than one genotype (up to 11).
The abundant replication of these viruses leads to a specific
cytopathic effect, and ISH experiments usually detect a
single EV HPV genotype in each lesion. Upon their third or
fourth decade, about half of the patients start developing
AK and Bowen’s carcinoma in situ, which evolve into inva-
sive NMSC (mostly SCC). In contrast with the great diversity
of EV HPV observed in benign lesions, EV carcinomas are
predominantly associated with HPV5 or, in single cases,
with HPV8, 14,17, 20, or 47, and high levels of transcripts of
the E6/E7 region are detected. This indicates that only a
subset of EV HPV is endowed with an oncogenic potential.
EV cancers usually arise on sun-exposed areas of the skin
and a syncarcinogenic role of HPV5 and UVR is supported
by the frequent mutations of the p53 gene in premalignant
and malignant EV tumors (Padlewska et al, 2001).
EV HPV cause widespread asymptomatic infections in
the general population (Antonsson et al, 2003). Recent
studies have disclosed that EV HPV infections are under the
control of two genes of unknown function, EVER1 and EV-
ER2, which are mutated in EV patients (Ramoz et al, 2002).
Furthermore, an EV-like syndrome has been found to occur
frequently after hematopoietic stem-cell transplantation in
patients with a severe combined immune deficiency caused
by common gc cytokine receptor subunit or JAK-3 defi-
ciency. This may suggest that gc/JAK-3 signaling in kera-
tinocytes could have a role in EV HPV immunity (Laffort et al,
2004). Focusing not only on HPV but also on the genes
controlling these viruses should provide clues to our under-
standing of the role of EV HPV in the skin carcinogenesis
process in non-EV patients.
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